GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cochlear Ltd (ASX:COH) » Definitions » Institutional Ownership

Cochlear (ASX:COH) Institutional Ownership : 34.21% (As of May. 17, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Cochlear Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cochlear's institutional ownership is 34.21%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cochlear's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cochlear's Float Percentage Of Total Shares Outstanding is 0.00%.


Cochlear Institutional Ownership Historical Data

The historical data trend for Cochlear's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cochlear Institutional Ownership Chart

Cochlear Historical Data

The historical data trend for Cochlear can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 34.96 34.66 34.16 34.06 33.93 33.82 33.58 34.15 34.19 34.21

Cochlear Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Cochlear (ASX:COH) Business Description

Traded in Other Exchanges
Address
1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109
Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.

Cochlear (ASX:COH) Headlines

No Headlines